Suwa T - Search Results

1

Characteristics of gut microbiome, organic acid profiles and viral antibody indexes of healthy Japanese with live Lacticaseibacillus detected in stool.

Shima T, Kaga C, Shimamoto K, Sugimoto T, Kado Y, Watanabe O, Suwa T, Amamoto R, Tsuji H, Matsumoto S. Shima T, et al. Among authors: suwa t. Benef Microbes. 2022 Feb 28;13(1):33-46. doi: 10.3920/BM2021.0101. Epub 2022 Feb 11. Benef Microbes. 2022. PMID: 35144523

2

Potential factors correlating to the PMDA's decision to waive Japanese Phase 2 and 3 studies for oncology drugs New Drug Application in Japan.

Nakajima K, Chiba K, Tsubamoto H, Walsh J, Strawn L, Suwa T. Nakajima K, et al. Among authors: suwa t. Invest New Drugs. 2013 Aug;31(4):1051-5. doi: 10.1007/s10637-012-9911-x. Epub 2012 Dec 19. Invest New Drugs. 2013. PMID: 23250712

3

Efficient clinical trials in Japan: Bridging studies versus participation in global clinical trials.

Shirotani M, Suwa T, Kurokawa T, Chiba K. Shirotani M, et al. Among authors: suwa t. J Clin Pharmacol. 2014 Apr;54(4):438-45. doi: 10.1002/jcph.216. Epub 2013 Nov 19. J Clin Pharmacol. 2014. PMID: 24165947

4

Population pharmacokinetic analysis of linezolid in patients with infectious disease: application to lower body weight and elderly patients.

Abe S, Chiba K, Cirincione B, Grasela TH, Ito K, Suwa T. Abe S, et al. Among authors: suwa t. J Clin Pharmacol. 2009 Sep;49(9):1071-8. doi: 10.1177/0091270009337947. Epub 2009 Jun 23. J Clin Pharmacol. 2009. PMID: 19549796

5

Pharmacokinetics of tolterodine in Japanese and Koreans: physiological and stochastic assessment of ethnic differences.

Oishi M, Chiba K, Malhotra B, Suwa T. Oishi M, et al. Among authors: suwa t. Drug Metab Pharmacokinet. 2011 Jun;26(3):236-41. doi: 10.2133/dmpk.DMPK-10-RG-112. Epub 2011 Jan 25. Drug Metab Pharmacokinet. 2011. PMID: 21273733 Free article.

6

Different truncation methods of AUC between Japan and the EU for bioequivalence assessment: influence on the regulatory judgment.

Oishi M, Chiba K, Fukushima T, Tomono Y, Suwa T. Oishi M, et al. Among authors: suwa t. Drug Metab Pharmacokinet. 2012;27(6):658-62. doi: 10.2133/dmpk.dmpk-12-rg-033. Epub 2012 May 22. Drug Metab Pharmacokinet. 2012. PMID: 22673011 Free article.

7

Pharmacokinetic-pharmacodynamic analysis of azithromycin extended release in Japanese patients with common respiratory tract infectious disease.

Muto C, Liu P, Chiba K, Suwa T. Muto C, et al. Among authors: suwa t. J Antimicrob Chemother. 2011 Jan;66(1):165-74. doi: 10.1093/jac/dkq398. Epub 2010 Nov 8. J Antimicrob Chemother. 2011. PMID: 21059616 Clinical Trial.

8

Low-molecular-weight heparin pharmacokinetics: a dual absorption model approach.

Abe S, Chiba K, Suwa T. Abe S, et al. Among authors: suwa t. Int J Clin Pharmacol Ther. 2013 Jun;51(6):482-9. doi: 10.5414/CP201858. Int J Clin Pharmacol Ther. 2013. PMID: 23587152 Clinical Trial.

9

Inter-individual variability of in vivo CYP2D6 activity in different genotypes.

Chiba K, Kato M, Ito T, Suwa T, Sugiyama Y. Chiba K, et al. Among authors: suwa t. Drug Metab Pharmacokinet. 2012;27(4):405-13. doi: 10.2133/dmpk.dmpk-11-rg-078. Epub 2012 Jan 24. Drug Metab Pharmacokinet. 2012. PMID: 22277677 Free article.

10

Population pharmacokinetic and pharmacodynamic modeling of pegvisomant in asian and Western acromegaly patients.

Muto C, Chiba K, Suwa T. Muto C, et al. Among authors: suwa t. J Clin Pharmacol. 2011 Dec;51(12):1628-43. doi: 10.1177/0091270010386954. Epub 2011 Jan 5. J Clin Pharmacol. 2011. PMID: 21209237 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters